LeadIQ logo
Learn more at LeadIQ.com
Black Diamond Therapeutics logo

Black Diamond Therapeutics Employee Directory

Biotechnology ResearchMassachusetts, United States11-50 Employees

Black Diamond Therapeutics is a clinical-stage biotechnology company focused on oncology. It develops therapies designed to target families of oncogenic mutations to broaden the patient population by offering one solution for multiple mutations, with the aim of overcoming resistance to cancer treatments and extending patients' lives. The company is based in Cambridge, Massachusetts, and is advancing silevertinib, a brain-penetrant fourth-generation EGFR inhibitor for non-small cell lung cancer and glioblastoma.

It has a licensing collaboration with Servier to develop BDTX-4933 for RAF- and RAS-mutant solid tumors, including NSCLC. In 2026 the company has announced participation in major oncology events, including the Jefferies Global Healthcare Conference and the ASCO Annual Meeting, reflecting ongoing clinical activity.

Find Black Diamond Therapeutics employees' phone numbers or email addresses

Black Diamond Therapeutics Global Highlights

Location
Employees

North America
40

Minus sign iconPlus sign icon
  • United States Of America
    38
  • Canada
    2

Africa
1

Minus sign iconPlus sign icon
  • Nigeria
    1

Black Diamond Therapeutics's Leadership

  • Stylized image of a person
    S. Y.
    Research Scientist
    Phone icon
    Mobile Phone

Black Diamond Therapeutics Employee Metrics

100%
50%
0%
2026
2025
  • Operations
  • Research
  • Engineering
  • Accounting
  • Business
  • Other
  • Quality Assurance
  • Consultant
  • Finance
  • Recruiting
  • Analytics
  • Biotechnology
  • Legal
  • Entrepreneurship
  • Sales

Contact profiles from Black Diamond Therapeutics

Name
Title
Contact Info
Location
Last Update
  • Stylized image of a person
    S. Y.
    Research Scientist
    Phone icon
    Mobile Phone
    Oct 17, 2024

Frequently Asked Questions

What is Black Diamond Therapeutics known for?

Minus sign iconPlus sign iconBlack Diamond Therapeutics was founded in 2017 operates in the Biotechnology Research industry. Explore Black Diamond Therapeutics's company overview page for more information.

What is Black Diamond Therapeutics's most common email format?

Minus sign iconPlus sign iconBlack Diamond Therapeutics employees' email format typically follows the pattern of . Trying to find reliable and up-to-date employee contact data? Find more Black Diamond Therapeutics email formats with LeadIQ.

How many employees does Black Diamond Therapeutics have currently?

Minus sign iconPlus sign iconBlack Diamond Therapeutics has approximately 29 employees as of July 2026. These team members are located across 2 continents, including North AmericaAfrica.

Who are Black Diamond Therapeutics's key employees and leadership?

Minus sign iconPlus sign icon

As of July 2026, Black Diamond Therapeutics's key employees include:

  • Research Scientist: S. Y.

Looking for contact data? Unlock accurate emails and phone numbers for your ideal prospects with LeadIQ.

Everything for prospecting,
in one platform.

What you can expect from LeadIQ:

  • B2B data verified in real-time
  • Sync data to your CRM, & add it to an outreach sequence in one click
  • Integrations with your tech stack for optimal efficiency
  • A patented AI cold email generator
  • Account & contact-level job change tracking

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.